Enovix price target lowered to $22.50 from $26.50 at Piper Sandler

Piper Sandler analyst Alexander Potter lowered the firm’s price target on Enovix to $22.50 from $26.50 and keeps an Overweight rating on the shares. The analyst updated the model to reflect the company’s revised production guidance.